Organisation paid for research Program year 2022 Source: CMS Open Payments

V Royter MD APMC

Neither a doctor nor a teaching hospital

Research payments

$389,349

9 payments

Through program year 2022, V Royter MD APMC is reported as receiving $389,349 in research payments, across 9 payments.

By program year

3 rows

Year	Kind	Amount	Payments
2022	Research	$9,904	3
2021	Research	$138,776	3
2020	Research	$240,669	3

Breakdown

Who paid Research payments · program years 2020–2022

Biogen, Inc. $389,349 9 payments

Studies the money was for Research payments · program years 2020–2022

Phase 2 Study of BIIB092 in Participants With Early Alzheimer's Disease $336,583 2 payments
Dimethyl Fumarate (DMF) Observational Study $36,659 2 payments
Plegridy Observational Program $6,203 2 payments
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety, Tolerability, and Efficacy of BIIB092 in Subjects with Mild Cognitive Impairment due to Alzheimer's Disease or with Mild Alzheimer's Disease $5,962 1 payment
Plegridy (peginterferon 1a) Real World Effectiveness and Safety Observational Program $2,435 1 payment
A Multicenter, Global, Observational Study to Collect Information on Safety and to Document the Drug Utilization of Tecfidera (Dimethyl Fumarate) When Used in Routine Medical Practice in the Treatment of Multiple Sclerosis (ESTEEM) $1,507 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.